Impaired consciousness at stroke onset in large hemisphere infarction: incidence, risk factors and outcome

Jie Li, Ping Zhang, Simiao Wu, Ruozhen Yuan, Junfeng Liu, Wendan Tao, Deren Wang, Ming Liu, Jie Li, Ping Zhang, Simiao Wu, Ruozhen Yuan, Junfeng Liu, Wendan Tao, Deren Wang, Ming Liu

Abstract

Impaired consciousness (IC) at stroke onset in large hemispheric infarctions (LHI) patients is common in clinical practice. However, little is known about the incidence and risk factors of IC at stroke onset in LHI. Besides, stroke-related complications and clinical outcomes in relation to the development of IC has not been systematically examined. Data of 256 consecutive patients with LHI were collected. IC at stroke onset was retrospectively collected from the initial emergency department and/or admission records. Of the 256 LHI patients enrolled, 93 (36.3%) had IC at stroke onset. LHI patients with IC at stroke onset were older (median age 66 vs. 61, p = 0.041), had shorter prehospital delay (24 vs. 26 h, p < 0.001and higher baseline National Institutes of Health Stroke Scale (NIHSS) score (19 vs. 12, p < 0.001). Independent risk factors of IC at stroke onset were high NIHSS score (odds ratio, OR 1.17, 95% confidence interval [CI] 1.12 to 1.23) and atrial fibrillation (OR 1.93, 95% CI 1.07 to 3.47). Dyslipidemia appeared to protect against IC at stroke onset (adjusted OR 0.416, 95% CI 0.175 to 0.988). IC at stroke onset was associated with higher frequency of stroke-related complications (90.32% vs. 67.48%, p < 0.001), especially brain edema (45.16% vs. 23.31%, p < 0.001) and pneumonia (63.44% vs. 47.82%, p = 0.019). The IC group had higher rates of in-hospital death (23.66% vs. 11.66%, p = 0.012), 3-month mortality (49.46% vs. 24.87%, p = 0.002), and 3-month unfavorable outcome (64.51% vs. 49.07%, p = 0.017). However, after adjusting for age, baseline NIHSS score and other confounders, IC at stroke onset was not an independent predictor of in-hospital death (adjusted OR 0.56, 95% CI 0.22 to 1.47), 3-month mortality (adjusted OR 0.54, 95% CI 0.25 to 1.14) and 3-month unfavorable outcome (adjusted OR 0.64, 95% CI 0.31 to 1.33) in LHI patients (all p > 0.05). Our results suggested that IC occur in 1 out of every 3 LHI patients at stroke onset and was associated with initial stroke severity and atrial fibrillation. LHI patients with IC at stroke onset more frequently had stroke-related complications, 3-month mortality and unfavorable outcome, whereas IC was not an independent predictor of poor outcomes.

Conflict of interest statement

The authors declare no competing interests.

Figures

Figure 1
Figure 1
3-month survival curves for LHI patients with or without impaired consciousness at stroke onset.

References

    1. Zeman AZ, Grayling AC, Cowey A. Contemporary theories of consciousness. J. Neurol. Neurosurg. Psychiatry. 1997;62:549.
    1. Goldfine AM, Schiff ND. Consciousness: its neurobiology and the major classes of impairment. Neurol. Clin. 2011;29:723–737.
    1. Lai P-F, Yiang G-T, Tsai M-J, Hu S-C. Analysis of patients with altered mental status in an emergency Department of Eastern Taiwan. Tzu Chi Med. J. 2009;21:151–155.
    1. Levy DE, et al. Prognosis in nontraumatic coma. Ann. Intern. Med. 1981;94:293–301.
    1. Melo TP, De Mendonca A, Crespo M, Carvalho M, Ferro JM. An emergency room-based study of stroke coma. Cerebrovasc. Dis. 1992;2:93–101.
    1. Li J, et al. Early consciousness disorder in acute ischemic stroke: incidence, risk factors and outcome. BMC Neurol. 2016;16:140.
    1. Schwarz S, Egelhof T, Schwab S, Hacke W. Basilar artery embolism: clinical syndrome and neuroradiologic patterns in patients without permanent occlusion of the basilar artery. Neurology. 1997;49:1346–1352.
    1. Huttner HB, Schwab S. Malignant middle cerebral artery infarction: clinical characteristics, treatment strategies, and future perspectives. Lancet Neurol. 2009;8:949–958.
    1. Hacke W, et al. 'Malignant' middle cerebral artery territory infarction: clinical course and prognostic signs. Arch. Neurol. 1996;53:309–315.
    1. Berrouschot J, Sterker M, Bettin S, Köster J, Schneider D. Mortality of space-occupying (‘malignant’) middle cerebral artery infarction under conservative intensive care. Intensive Care Med. 1998;24:620–623.
    1. Frank JI. Large hemispheric infarction, deterioration, and intracranial pressure. Neurology. 1995;45:1286–1290.
    1. Krieger DW, Demchuk AM, Kasner SE, Jauss M, Hantson L. Early clinical and radiological predictors of fatal brain swelling in ischemic stroke. Stroke. 1999;30:287–292.
    1. Steiner T, Ringleb P, Hacke W. Treatment options for large hemispheric stroke. Neurology. 2001;57:S61–S68.
    1. Vahedi K, et al. Early decompressive surgery in malignant infarction of the middle cerebral artery: a pooled analysis of three randomised controlled trials. Lancet Neurol. 2007;6:215–222.
    1. Frankel MR, et al. Predicting prognosis after stroke: a placebo group analysis from the National Institute of neurological disorders and stroke rt-PA stroke trial. Neurology. 2000;55:952–959.
    1. Rordorf G, Koroshetz W, Efird JT, Cramer SC. Predictors of mortality in stroke patients admitted to an intensive care unit. Crit. Care Med. 2000;28:1301–1305.
    1. Kasner SE, et al. Predictors of fatal brain edema in massive hemispheric ischemic stroke. Stroke. 2001;32:2117–2123.
    1. Uhl E, et al. Outcome and prognostic factors of hemicraniectomy for space occupying cerebral infarction. J. Neurol. Neurosurg. Psychiatry. 2004;75:270–274.
    1. De Haan R, Limburg M, Bossuyt P, Van der Meulen J, Aaronson N. The clinical meaning of Rankin ‘handicap’ grades after stroke. Stroke. 1995;26:2027–2030.
    1. Li J, et al. Factors associated with favourable outcome in large hemispheric infarctions. BMC Neurol. 2018;18:152.
    1. Adams HP, Jr, et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in acute stroke treatment. Stroke. 1993;24:35–41.
    1. Johnston KC, et al. Medical and neurological complications of ischemic stroke: experience from the RANTTAS trial. Stroke. 1998;29:447–453.
    1. Li J, et al. Stroke-related complications in large hemisphere infarction: incidence and influence on unfavorable outcome. Ther Adv Neurol Disorders. 2019;12:1756286419873264.
    1. Ropper A, Samuels M. Adams and Victor's Principles of Neurology. 9. New York: McGraw-Hill professional; 2009.
    1. Limburg M, Van Royen EA, Hijdra A, De Bruine JF, Verbeeten BW., Jr Single-photon emission computed tomography and early death in acute ischemic stroke. Stroke. 1990;21:1150–1155.
    1. Thomalla G, et al. Prediction of malignant middle cerebral artery infarction by magnetic resonance imaging within 6 hours of symptom onset: a prospective multicenter observational study. Ann. Neurol. 2010;68:435–445.
    1. Minnerup J, et al. Prediction of malignant middle cerebral artery infarction using computed tomography-based intracranial volume reserve measurements. Stroke. 2011;42:3403–3409.
    1. Berrouschot JR, et al. 99mTechnetium-ethyl-cysteinate-dimer single-photon emission CT can predict fatal ischemic brain edema. Stroke. 1998;29:2556–2562.
    1. Cucchiara BL, et al. Early impairment in consciousness predicts mortality after hemispheric ischemic stroke. Crit. Care Med. 2004;32:241–245.
    1. Heinsius T, Bogousslavsky J, Van Melle G. Large infarcts in the middle cerebral artery territory Etiology and outcome patterns. Neurology. 1998;50:341–350.
    1. Timsit SG, et al. Early clinical differentiation of cerebral infarction from severe atherosclerotic stenosis and cardioembolism. Stroke. 1992;23:486–491.
    1. Lamassa M, et al. Characteristics, outcome, and care of stroke associated with atrial fibrillation in Europe: data from a multicenter multinational hospital-based registry (The European Community Stroke Project) Stroke. 2001;32:392–398.
    1. Arboix A, Alioc J. Cardioembolic stroke: clinical features, specific cardiac disorders and prognosis. Current Cardiol. Rev. 2010;6:150–161.
    1. Ropper AH. Lateral displacement of the brain and level of consciousness in patients with an acute hemispheral mass. N. Engl. J. Med. 1986;314:953–958.
    1. Ropper AH. A preliminary MRI study of the geometry of brain displacement and level of consciousness with acute intracranial masses. Neurology. 1989;39:622–622.
    1. Olsen TS, Christensen RH, Kammersgaard LP, Andersen KK. Higher total serum cholesterol levels are associated with less severe strokes and lower all-cause mortality ten-year follow-up of ischemic strokes in the copenhagen stroke study. Stroke. 2007;38:2646–2651.
    1. Balami JS, Chen R-L, Grunwald IQ, Buchan AM. Neurological complications of acute ischaemic stroke. Lancet Neurol. 2011;10:357–371.
    1. Kumar S, Selim MH, Caplan LR. Medical complications after stroke. Lancet Neurol. 2010;9:105–118.
    1. Hofmeijer J, Algra A, Kappelle LJ, Van Der Worp HB. Predictors of life-threatening brain edema in middle cerebral artery infarction. Cerebrovasc. Dis. 2008;25:176–184.
    1. Wu S, et al. Early prediction of malignant brain edema after ischemic stroke: a systematic review and meta-analysis. Stroke. 2018;49:2918–2927.
    1. Mori K, Aoki A, Yamamoto T, Horinaka N, Maeda M. Aggressive decompressive surgery in patients with massive hemispheric embolic cerebral infarction associated with severe brain swelling. Acta Neurochir. 2001;143:483–492.
    1. Koennecke HC, et al. Factors influencing in-hospital mortality and morbidity in patients treated on a stroke unit. Neurology. 2011;77:965–972.
    1. Westendorp WF, Nederkoorn PJ, Vermeij J-D, Dijkgraaf MG, van de Beek D. Post-stroke infection: a systematic review and meta-analysis. BMC Neurol. 2011;11:110.
    1. Ji R, et al. Interrelationship among common medical complications after acute stroke: pneumonia plays an important role. Stroke. 2013;44:3436–3444.
    1. Westendorp WF, et al. The preventive antibiotics in stroke study (PASS): a pragmatic randomised open-label masked endpoint clinical trial. The Lancet. 2015;385:1519–1526.
    1. Kalra L, et al. Prophylactic antibiotics after acute stroke for reducing pneumonia in patients with dysphagia (STROKE-INF): a prospective, cluster-randomised, open-label, masked endpoint, controlled clinical trial. The Lancet. 2015;386:1835–1844.
    1. Dziewas R, et al. Pneumonia in acute stroke patients fed by nasogastric tube. J. Neurol. Neurosurg. Psychiatry. 2004;75:852–856.
    1. Henke C, Foerch C, Lapa S. Early Screening Parameters for Dysphagia in Acute Ischemic Stroke. Cerebrovasc. Dis. 2017;44:285–290.
    1. Toscano M, Cecconi E, Capiluppi E, et al. Neuroanatomical, clinical and cognitive correlates of post-stroke dysphagia. Eur. Neurol. 2015;74:171–177.
    1. Toscano M, Vigano A, Piero VD. Commentary: early screening parameters for dysphagia in acute ischemic stroke. Frontiers Neurol. 2018;9:148.
    1. Roth EJ, et al. Incidence of and risk factors for medical complications during stroke rehabilitation. Stroke. 2001;32:523–529.
    1. Kalra L, Yu G, Wilson K, Roots P. Medical complications during stroke rehabilitation. Stroke. 1995;26:990–994.

Source: PubMed

Patrocinadores e Colaboradores

Condições médicas

Intervenções de drogas

3
Se inscrever